Opexa Collaborates with Merck Serono and 4 Stocks at 52-Week Highs

Opexa Therapeutics (NASDAQ:OPXA): Closing price $3.15

Opexa reached an agreement with Merck Serono, a unit of Merck for the development and commercialization of Tcelna, a potential first-in-class personalized T-cell therapy for patients with multiple sclerosis. Tcelna is being developed by Opexa and currently is in a Phase IIb clinical trial in patients suffering from Secondary Progressive MS. Potential payments to Opexa from the option and license agreement could amount to $225 million, based upon the successful development and commercialization of Tcelna for MS. Shares closed up 160.33 percent on the day at $3.15, and have been traded in a 52-week range of $1.07 to $4.60.

Your 1 Feature Stock Pick for February is hot off the press. Click here to discover it now!

opka

PDC Energy (PDCE): Closing price $41.17

PDC will divest its Piceance, NECO, and other non-core Colorado holdings to Caerus Oil and Gas at around $200 million in cash, subject to purchase price adjustments. The deal includes the buyer’s assumption of all PDC’s transport obligations connected to the sale assets along with certain natural gas hedging positions for the years 2013 through 2015. The effective date of the transaction is January 1st, and should close in the second quarter. Shares closed up 8.63 percent on the day at $41.17, and have been traded in a 52-week range of $19.33 to $40.26.

pdce

ePlus (NASDAQ:PLUS): Closing price $48.84

ePlus Technology, the subsidiary of ePlus (NASDAQ:PLUS), has won Authorized Service Provider Video Partner status from Cisco Systems (NASDAQ:CSCO). This designation complements ePlus as having fulfilled the training requirements and program prerequisites to sell, deploy, and support Cisco Service Provider Video Solutions. The Cisco Service Provider Video Program allows channel partners to identify, manage, and deliver end-to-end Cisco business and consumer video solutions for service providers. Shares closed up 2.61 percent on the day at $48.84, having been traded in a 52-week range of $29.00 to $48.89.

Your 1 Feature Stock Pick for February is hot off the press. Click here to discover it now!

plus

Revlon (NYSE:REV): Closing price $ 18.31

Revlon has posted its fourth quarter earnings at 89 cents, against one estimate of 73 cents. Shares closed up 18.13 percent on the day at $18.31, and have been traded in a 52-week range of $12.60 to $17.99.

rev

Retail Properties (NYSE:RPAI): Closing price $13.27

The percentage of retail properties being put into commercial mortgage-backed securities has fallen in recent years as the threat of online shopping and tougher competition has prompted some forecasters to estimate that up to 15 percent of domestic regional malls will close over the next five years, says the Financial Times. Among real estate investment trusts that invest in malls are Retail Properties of America, Simon Property Group (NYSE:SPG), General Growth Properties (NYSE:GGP), Macerich (NYSE:MAC), and Equity One (NYSE:EQY). Shares closed up 0.61 percent on the day at $13.27, having been traded in a 52-week range of $8.50 to $13.20.

rpai

Investing Insights: Will Disney’s Magical Ride Continue?